Abbott India Ltd. Technical Momentum Shifts Amid Mixed Market Signals

Current Price and Market Context

As of 31 July 2026, Abbott India’s stock closed at ₹27,566, down 0.56% from the previous close of ₹27,720.05. The intraday range saw a high of ₹27,815 and a low of ₹27,518.50. The stock remains well below its 52-week high of ₹35,280, yet comfortably above the 52-week low of ₹25,164, reflecting a moderate recovery from recent lows.

Technical Trend Evolution

The technical trend for Abbott India has shifted from mildly bearish to sideways, signalling a potential consolidation phase. This transition is underscored by mixed signals from key technical indicators across different timeframes.

MACD Analysis

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD is mildly bullish, suggesting some upward momentum in the short term. However, the monthly MACD remains bearish, indicating that longer-term momentum is still under pressure. This divergence implies that while short-term traders might find opportunities, the broader trend remains subdued.

RSI and Momentum Oscillators

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of directional bias suggests that the stock is neither overbought nor oversold, reinforcing the sideways trend narrative. Meanwhile, the Know Sure Thing (KST) oscillator is bullish on a weekly basis but bearish monthly, echoing the MACD’s mixed timeframe signals.

Bollinger Bands and Moving Averages

Bollinger Bands indicate mild bullishness weekly but mild bearishness monthly, further highlighting the stock’s consolidation phase. Daily moving averages are mildly bearish, reflecting recent price softness. This combination suggests that while short-term volatility may favour buyers, the overall trend remains cautious.

Volume and Dow Theory Signals

On-Balance Volume (OBV) readings are bullish on both weekly and monthly charts, signalling accumulation by investors despite price fluctuations. Dow Theory assessments also show mild bullishness across weekly and monthly timeframes, hinting at underlying strength that could support a potential breakout if confirmed by price action.

Comparative Returns and Market Performance

Abbott India’s recent returns present a mixed picture when compared with the broader Sensex index. Over the past week, the stock declined by 4.07%, contrasting with the Sensex’s 2.01% gain. However, over the last month, Abbott India outperformed with an 8.37% return against the Sensex’s 1.90%. Year-to-date, the stock has declined 5.17%, though this is less severe than the Sensex’s 8.56% fall.

Longer-term returns reveal further insights. Over one year, Abbott India’s stock has fallen 21.66%, significantly underperforming the Sensex’s 4.36% decline. Over three and five years, the stock has delivered 14.58% and 44.43% returns respectively, trailing the Sensex’s 17.79% and 48.19%. Notably, over a decade, Abbott India has surged 493.40%, vastly outperforming the Sensex’s 177.80%, underscoring its strong historical growth trajectory despite recent volatility.

Mojo Score and Rating Update

MarketsMOJO’s latest assessment assigns Abbott India a Mojo Score of 48.0, categorising it as a Sell with a mid-cap market cap grade. This represents a downgrade from the previous Hold rating issued on 12 May 2026. The downgrade reflects the deteriorating technical momentum and cautious outlook amid mixed signals from key indicators.

Investment Implications and Outlook

Investors should approach Abbott India with measured caution. The sideways technical trend and conflicting indicator signals suggest a period of consolidation rather than a clear directional move. The mildly bullish weekly MACD and OBV readings offer some hope for short-term gains, but the bearish monthly MACD and moving averages temper enthusiasm.

Given the stock’s recent underperformance relative to the Sensex and the downgrade to Sell, investors may prefer to monitor for confirmation of a sustained breakout above resistance levels before committing fresh capital. The stock’s strong long-term fundamentals and historical returns remain attractive, but near-term technical uncertainty warrants prudence.

Technical Summary and Final Assessment

In summary, Abbott India Ltd. is navigating a complex technical landscape. The shift from mildly bearish to sideways trend indicates a pause in momentum, with short-term bullish signals counterbalanced by longer-term bearishness. The absence of RSI extremes and bullish volume trends provide some support, but daily moving averages and monthly indicators caution against aggressive positioning.

For investors focused on technical momentum, Abbott India currently presents a mixed risk-reward profile. The stock’s mid-cap status and sector affiliation in Pharmaceuticals & Biotechnology add layers of fundamental interest, but the recent downgrade and technical ambiguity suggest waiting for clearer directional confirmation.

Market participants should continue to monitor key technical levels, volume patterns, and broader sector trends to gauge the stock’s next move. The interplay of weekly bullishness and monthly bearishness will be critical in determining whether Abbott India can regain upward momentum or face further downside pressure.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →